使用微剂量的布普伦诺芬诱导用于怀孕期间治疗阿片类药物使用障碍
Neil B Patel1, Barbara V Parilla1
1Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, University of Kentucky College of Medicine, Lexington, Kentucky.
布普伦诺芬微剂量成功地使一名孕妇患者从甲中转变,避免了阿片类药物戒断症状和新生儿阿片类药物戒断综合征 (NOWS). 这种方法对在怀孕期间管理阿片类药物使用障碍有希望.
科学领域:
- 产科和妇科 产科和妇科
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
背景情况:
- 传统的布普伦诺芬诱导需要阿片类药物戒断,往往导致戒断.
- 患有阿片类药物使用障碍的孕妇在治疗过渡时面临挑战.
- 尽量减少新生儿阿片类药物戒断综合征 (NOWS) 是产前护理的一个关键目标.
更多相关视频
04:13Less-Invasive Technique for Non-stabilized Mandibular Fracture in Mouse Models
Published on: September 27, 2024
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drugs for Treatment of Constipation-Predominant IBS
Factors Affecting Drug Response: Overview
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
